Correspondence 0001493152-23-007620 from MANGOCEUTICALS, INC. (MGRX)
MANGOCEUTICALS, INC.
Date: March 14, 2023 · CIK: 0001938046 · Accession: 0001493152-23-007620
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-269240
Letter
Re: Mangoceuticals, Inc.
March 14, 2023
VIA EDGAR
Division of Corporation Finance
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, DC 20549
Attn: Office of Industrial Applications and Services
Registration Statement on Form S-1
File No. 333-269240
Attention: Mr. Jimmy McNamara
Mr. Joe McCann
Acceleration Request
Request Date: Thursday, March 16, 2023
Request Time: 5:00 p.m. Eastern Time (or as soon thereafter as practicable)
Mr. McNamara:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mangoceuticals, Inc. (the “Registrant”) hereby requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-captioned Registration Statement (the “Registration Statement”) to become effective on Thursday, March 16, 2023, at 5:00 p.m., Eastern Time, or as soon thereafter as practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission.
The Registrant hereby authorizes David M. Loev and/or John S. Gillies of The Loev Law Firm, PC, to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm that event with David M. Loev of The Loev Law Firm, PC, corporate counsel to the Registrant, at (832) 930-6432.
Sincerely,
/s/ Jacob Cohen
Show Raw Text
CORRESP
1
filename1.htm
March 14, 2023
VIA EDGAR
Division of Corporation Finance
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, DC 20549
Attn: Office of Industrial Applications and Services
Re:
Mangoceuticals, Inc.
Registration Statement on Form S-1
File No. 333-269240
Attention:
Mr. Jimmy McNamara
Mr. Joe McCann
Acceleration Request
Request Date: Thursday, March 16, 2023
Request Time: 5:00 p.m. Eastern Time (or as
soon thereafter as practicable)
Mr. McNamara:
Pursuant to Rule 461 under the
Securities Act of 1933, as amended, Mangoceuticals, Inc. (the “Registrant”) hereby requests that the United States
Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-captioned Registration
Statement (the “Registration Statement”) to become effective on Thursday, March 16, 2023, at 5:00 p.m., Eastern Time,
or as soon thereafter as practicable or at such later time as the Registrant may orally request via telephone call to the staff of the
Commission.
The Registrant hereby authorizes
David M. Loev and/or John S. Gillies of The Loev Law Firm, PC, to orally modify or withdraw this request for acceleration.
Once the Registration Statement
has been declared effective, please orally confirm that event with David M. Loev of The Loev Law Firm, PC, corporate counsel to the Registrant,
at (832) 930-6432.
Sincerely,
/s/ Jacob Cohen
Jacob Cohen
Chief Executive Officer